c ebpβ-lip Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | Journal of Experimental & Clinical Cancer Research Inhibition of C/EBP activity by
Inhibition of C EBP activity by LIP expression inhibits the induction Download Scientific Diagram Continuous Activation of C EBP Transcription Factor Prevents Fibrosis Resolution After Alcohol Cessation Cellular and Molecular Gastroenterology and Hepatology C EBP beta Antibody Cell Signaling Technology c ebp lip drug Increasing intratumor C EBP LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer Journal of Experimental & Clinical Cancer Research A screening strategy for The Janus Role of C EBPs Family Members in Cancer Progression
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


